Concepedia

Sara A. Hurvitz

SA

Statistics

Publications

218

Citations

29.5K

H-Index

74

Active since

2005

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Sarah Cannon

Massachusetts General Hospital

Sara A. Hurvitz is an author at University of California, Los Angeles specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2005–2025

218

Publications

218

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton, Hope S. Rugo, Johannes Ettl et al. · New England Journal of Medicine · 2018 · 2.2K citations · Full text

, , +14

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi, Cristina Saura, Toshinari Yamashita et al. · New England Journal of Medicine · 2019 · 2K citations · Full text

, , +17

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

, , +17

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Alessandra Gennari, Fabrice André, Carlos H. Barrios et al. · Annals of Oncology · 2021 · 1.4K citations · Full text

, , +14

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Rashmi K. Murthy, Sherene Loi, Alicia Okines et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text

, , +12

1–5 of 218